Quantcast
Last updated on April 16, 2014 at 12:29 EDT

Latest Bioethics Stories

2013-09-03 23:04:06

Researchers from the Icahn School of Medicine at Mount Sinai recently published two manuscripts in the New England Journal of Medicine regarding a new antibody used to treat both ulcerative colitis and Crohn’s disease. New York, NY (PRWEB) September 03, 2013 Researchers from the Icahn School of Medicine at Mount Sinai recently published two manuscripts in the New England Journal of Medicine regarding a new antibody used to treat both ulcerative colitis and Crohn’s disease. The journal...

2013-09-03 08:28:13

ANNAPOLIS, Md., Sept. 3, 2013 /PRNewswire/ -- PharmAthene, Inc. (NYSE MKT: PIP), a biodefense company developing medical countermeasures against biological and chemical threats, announced today that Eric I. Richman, President and Chief Executive Officer will present at the Rodman & Renshaw Annual Global Investment Conference on Monday, September 9, 2013 at 10:25 a.m. EDT in Room 7.03, 7(th) Floor of the Millennium Broadway Hotel, New York. Event: Rodman & Renshaw...

2013-08-30 23:03:30

PharmScript offers insight on how long-term care facilities can work with pharmacy to comply with new CMS F309 Quality of Care Guidance regarding end of life care requirements. Edison, NJ (PRWEB) August 30, 2013 PharmScript reminds long-term care facilities that the Centers for Medicare and Medicaid Services (CMS) recently implemented new F309 Quality of Care Guidance to surveyors for determining nursing facility compliance with end of life care requirements. New guidelines specify that...

2013-08-27 12:24:32

ZURICH, August 27, 2013 /PRNewswire/ -- It is the second time that the Basel Declaration grants its "Award for Education in Animal Research". Chiara Ruzza, PhD in pharmacology and molecular oncology, is currently completing a post-doctorate at the University of Ferrara, Italy. The prize winner takes part in a one-week course on Animal research at the University of Zurich, based on the rules of the 3Rs (Replace, Reduce, Refine). She has been mandated by her university to set up...

2013-08-08 13:57:33

A team from the University of Washington has unveiled a comprehensive portrait of the genome of the world’s first immortal cell line, known as HeLa. The cell line was derived in 1951 from an aggressive cervical cancer that killed Henrietta Lacks, a 31-year-old African-American tobacco farmer and mother of five – the subject of the 2010 New York Times best-seller, “The Immortal Life of Henrietta Lacks.” They will also be...

2013-08-08 10:14:45

The National Institutes of Health today announced in Nature that it has reached an understanding with the family of the late Henrietta Lacks to allow biomedical researchers controlled access to the whole genome data of cells derived from her tumor, commonly known as HeLa cells. These cells have already been used extensively in scientific research and have helped make possible some of the most important medical advances of the past 60 years. These include the development of modern vaccines,...

2013-08-05 04:21:34

-Provides Further Evidence of Long-term Efficacy- LONDON, Aug. 5, 2013 /PRNewswire/ -- GW Pharmaceuticals plc (NASDAQ: GWPH, AIM: GWP, "GW," "the Company" or "the Group"), a biopharmaceutical company focused on discovering, developing and commercializing novel therapeutics from its proprietary cannabinoid product platform, announces top-line results from a 12 month placebo-controlled study of Sativex in patients with spasticity due to Multiple Sclerosis (MS). The study results...

2013-08-01 14:47:55

Conditioning, association affect people's responses to placebos Not all placebos are equal, and patients who respond to one placebo don't always respond to others, according to research published July 31 in the open access journal PLOS ONE by Jian Kong from Massachusetts General Hospital, Harvard Medical School and colleagues from other institutions. The researchers tested the analgesic effects of genuine acupuncture, sham acupuncture and a placebo pill on healthy participants' pain...

2013-08-01 14:37:49

In an editorial published online today in BMJ, bioethicist Jeremy Sugarman and other experts warn that action is urgently needed to deal with possible unintended consequences of India’s new policy to protect research participants. Passed earlier this year, the Drugs and Cosmetics Act (First Amendment) Rules, was meant to mitigate ethical concerns with potential serious consequences for public health, as well as India’s viability as a continued global...

2013-08-01 12:29:30

TOKYO, Aug. 1, 2013 /PRNewswire/ -- Today, Astellas Pharma Inc. (TSE: 4503) became aware of an error in the English translation of the FY2013 1Q earnings call citing incorrect timing of the PREVAIL interim analysis. The company's guidance has not changed and Astellas confirms that the interim analysis of the XTANDI PREVAIL study will occur within calendar year 2013. Important Safety Information Contraindications- XTANDI can cause fetal harm when administered to a pregnant...


Latest Bioethics Reference Libraries

OncoMouse
2013-10-02 09:29:43

The OncoMouse or Harvard Mouse is a type of laboratory mouse that has been genetically modified utilizing modification designed by Philip Leder and Timothy A. Stewart, of Harvard University, to carry a certain gene called an activated oncogene. The activated oncogene considerably increases the mouse’s vulnerability to cancer, therefore making the mouse suitable for cancer research. The rights to the invention were owned by DuPont until recently. The USPTO found that the patent expired in...

More Articles (1 articles) »